Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.1%
|
$0
$0.46 P/Share
|
|
Sep 07
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.39%
|
$2,430,000
$81.41 P/Share
|
|
Aug 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.2%
|
$405,000
$81.47 P/Share
|
|
Aug 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.5%
|
$0
$0.46 P/Share
|
|
Aug 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-2.43%
|
$648,000
$72.79 P/Share
|
|
Aug 18
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+18.53%
|
$0
$0.46 P/Share
|
|
Aug 18
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.17%
|
$0
$0.43 P/Share
|
|
Aug 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$637,000
$91.99 P/Share
|
|
Aug 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.33%
|
$475,000
$95.06 P/Share
|
|
Aug 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.43%
|
$0
$0.46 P/Share
|
|
Aug 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.33%
|
$2,790,000
$93.21 P/Share
|
|
Jul 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$420,000
$84.51 P/Share
|
|
Jul 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.5%
|
$0
$0.46 P/Share
|
|
Jul 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.16%
|
$765,000
$85.28 P/Share
|
|
Jul 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.76%
|
$460,000
$92.3 P/Share
|
|
Jul 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.43%
|
$0
$0.46 P/Share
|
|
Jul 09
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.04%
|
$644,000
$92.27 P/Share
|
|
Jul 07
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
69,915
-1.44%
|
$6,432,180
$92.26 P/Share
|
|
Jul 06
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,085
-1.38%
|
$5,647,990
$94.18 P/Share
|
|
Jul 06
2021
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-0.06%
|
$43,890
$95.99 P/Share
|
|
Jul 06
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-0.34%
|
$21,945
$95.99 P/Share
|
|
Jul 06
2021
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
240
-0.49%
|
$22,800
$95.99 P/Share
|
|
Jul 06
2021
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-0.18%
|
$32,965
$95.99 P/Share
|
|
Jun 28
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.18%
|
$480,000
$96.18 P/Share
|
|
Jun 28
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.46%
|
$0
$0.46 P/Share
|
|
Jun 21
2021
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+50.0%
|
-
|
|
Jun 21
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
1,001
-0.49%
|
$91,091
$91.41 P/Share
|
|
Jun 18
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
7,999
-1.31%
|
$727,909
$91.85 P/Share
|
|
Jun 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$630,000
$90.18 P/Share
|
|
Jun 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.76%
|
$450,000
$90.72 P/Share
|
|
Jun 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
Jun 04
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.66%
|
$2,460,000
$82.72 P/Share
|
|
May 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.17%
|
$435,000
$88.0 P/Share
|
|
May 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.46%
|
$0
$0.05 P/Share
|
|
May 27
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+4.47%
|
-
|
|
May 27
2021
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+0.56%
|
-
|
|
May 27
2021
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+1.21%
|
-
|
|
May 27
2021
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+0.26%
|
-
|
|
May 27
2021
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+0.57%
|
-
|
|
May 27
2021
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+4.47%
|
-
|
|
May 27
2021
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+2.65%
|
-
|
|
May 27
2021
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+5.7%
|
-
|
|
May 25
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.92%
|
$0
$0.05 P/Share
|
|
May 20
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.64%
|
$0
$0.43 P/Share
|
|
May 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.49%
|
$738,000
$82.58 P/Share
|
|
May 13
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
93,972
+15.26%
|
-
|
|
May 13
2021
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
3,389,511
-100.0%
|
-
|
|
May 13
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
685,826
+50.0%
|
-
|
|
May 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$630,000
$90.72 P/Share
|
|
May 10
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.75%
|
$450,000
$90.49 P/Share
|